Archives: Press Releases

Initial Proof-of-Concept Work Suggests Strong Potential to Further Improve PacBio’s Highly Accurate HiFi Sequencing with Google Deep Learning Technologies MENLO PARK, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ:…

MENLO PARK, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced unaudited preliminary revenue of approximately $36.0 million…

Added Whole Genome Sequencing Capacity Enables the SOLVE-RD Research Program to Significantly Increase Sample Throughput MENLO PARK, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) — PacBio (Nasdaq: PACB), a leading developer…

PacBio’s Sequel IIe Devices Will Support Genomic Researchers Around the World MENLO PARK, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) — PacBio (Nasdaq: PACB) today announced an expansion of its extensive…

The Study Will Evaluate the Impact of High-Resolution Genomes Generated on PacBio Technology in Studying Unsolved Rare Disease Cases MENLO PARK, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) — PacBio, a…

MENLO PARK, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) — PacBio announced today that its executives will be speaking virtually at the following investor conference: 40th Annual J.P. Morgan Healthcare Conference…

HiFiViral Solution Helps to Accelerate Understanding of the Omicron Variant, Providing Information that is Important to Public Health Response MENLO PARK, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) — PacBio (Nasdaq:…

Collaboration Aims to Identify Variants Not Easily Detectible by Short-Read Sequencing, Increasing Diagnostic Yield in Rare Disease Patients MENLO PARK, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) — PacBio (Nasdaq: PACB),…

MENLO PARK, Calif., Dec. 03, 2021 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s…

Strategic Hire Will Expand Company’s Commercial Presence in Key Geography MENLO PARK, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) — PacBio (NASDAQ:PACB), a leading provider of high-quality, long-read sequencing platforms, welcomes…

MENLO PARK, Calif., Nov. 19, 2021 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s…

Whole Genome HiFi Sequencing Will Be Used on Unexplained Rare Disease Cases to Evaluate If It Can Identify Variants Not Readily Detectable by Short-Read Sequencing MENLO PARK, Calif., Nov. 18,…

Robust SARS-CoV-2 Sequencing Kit and Upgraded Microbial Whole Genome Assembly Workflow Enable Public Health Laboratories to Scale Pathogen Surveillance Programs MENLO PARK, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) — PacBio…

MENLO PARK, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) — PacBio announced today that its executives will be speaking at the following investor conferences: Stifel 2021 Virtual Healthcare Conference on November…

MENLO PARK, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2021. Record revenue reflects 6th straight quarter of…